Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-012170
Filing Date
2022-03-24
Accepted
2022-03-24 21:22:18
Documents
2
Period of Report
2022-03-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3608
2 EX-24 DOCUMENT attachment1.htm EX-24 3689
  Complete submission text file 0000899243-22-012170.txt   8622
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Issuer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 821 WASHINGTON ST. CAPE MAY NJ 08204
Business Address
Marks Gilbert Lynn (Reporting) CIK: 0001916940 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41331 | Film No.: 22768073